Henry Schein, Inc. (NASDAQ:HSIC) Given Average Recommendation of “Hold” by Brokerages

Shares of Henry Schein, Inc. (NASDAQ:HSIC – Get Rating) have been assigned an average recommendation of “Hold” from the eleven brokerages that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating on the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $85.67.

Several analysts have recently weighed in on HSIC shares. Morgan Stanley lowered their target price on Henry Schein from $70.00 to $69.00 and set an “underweight” rating for the company in a research note on Tuesday, February 21st. Credit Suisse Group decreased their price target on Henry Schein from $99.00 to $97.00 and set an “outperform” rating for the company in a research note on Tuesday, February 28th. UBS Group lifted their price target on Henry Schein from $75.00 to $82.00 and gave the stock a “neutral” rating in a research note on Tuesday, March 7th. Barrington Research decreased their price target on Henry Schein from $92.00 to $90.00 in a research note on Wednesday, May 10th. Finally, Piper Sandler lifted their price target on Henry Schein from $85.00 to $97.00 and gave the stock an “overweight” rating in a research note on Monday, February 6th.

Insider Activity at Henry Schein

In related news, Director Philip A. Laskawy sold 6,405 shares of Henry Schein stock in a transaction on Friday, March 3rd. The shares were sold at an average price of $78.74, for a total value of $504,329.70. Following the completion of the sale, the director now owns 26,239 shares of the company’s stock, valued at approximately $2,066,058.86. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Henry Schein news, Director Philip A. Laskawy sold 6,405 shares of the business’s stock in a transaction on Friday, March 3rd. The shares were sold at an average price of $78.74, for a total transaction of $504,329.70. Following the completion of the transaction, the director now owns 26,239 shares of the company’s stock, valued at approximately $2,066,058.86. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Kurt P. Kuehn sold 1,909 shares of the business’s stock in a transaction on Thursday, March 16th. The stock was sold at an average price of $77.46, for a total transaction of $147,871.14. Following the transaction, the director now directly owns 15,675 shares of the company’s stock, valued at approximately $1,214,185.50. The disclosure for this sale can be found here. 1.14% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in HSIC. Chevy Chase Trust Holdings LLC increased its stake in Henry Schein by 1.0% in the first quarter. Chevy Chase Trust Holdings LLC now owns 83,310 shares of the company’s stock valued at $6,793,000 after acquiring an additional 808 shares during the period. Snyder Capital Management L P grew its stake in Henry Schein by 2.8% during the first quarter. Snyder Capital Management L P now owns 965,552 shares of the company’s stock worth $78,731,000 after buying an additional 26,663 shares during the last quarter. Balyasny Asset Management L.P. grew its stake in Henry Schein by 4,213.8% during the first quarter. Balyasny Asset Management L.P. now owns 121,519 shares of the company’s stock worth $9,909,000 after buying an additional 118,702 shares during the last quarter. Cubist Systematic Strategies LLC grew its stake in Henry Schein by 42.0% during the first quarter. Cubist Systematic Strategies LLC now owns 10,822 shares of the company’s stock worth $882,000 after buying an additional 3,201 shares during the last quarter. Finally, Lido Advisors LLC grew its stake in Henry Schein by 93.7% during the first quarter. Lido Advisors LLC now owns 13,033 shares of the company’s stock worth $1,063,000 after buying an additional 6,305 shares during the last quarter. Institutional investors own 95.45% of the company’s stock.

Henry Schein Stock Up 0.5 %

Shares of NASDAQ HSIC opened at $76.92 on Monday. Henry Schein has a 12-month low of $64.75 and a 12-month high of $89.72. The company has a market cap of $10.08 billion, a P/E ratio of 21.98, a P/E/G ratio of 2.15 and a beta of 0.82. The company has a current ratio of 1.82, a quick ratio of 0.94 and a debt-to-equity ratio of 0.25. The stock has a fifty day moving average price of $80.34 and a 200 day moving average price of $80.82.

Henry Schein (NASDAQ:HSIC – Get Rating) last announced its earnings results on Tuesday, May 9th. The company reported $1.21 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.02). The business had revenue of $3.06 billion for the quarter, compared to analyst estimates of $3.09 billion. Henry Schein had a net margin of 3.82% and a return on equity of 15.41%. The firm’s revenue was down 3.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.30 earnings per share. Research analysts anticipate that Henry Schein will post 5.26 EPS for the current fiscal year.

About Henry Schein

(Get Rating)

Henry Schein, Inc engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins.